Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery. N Engl J Med. 2005;352:1081 91. 27. Ott E, Nussmeier NA, Duke PC, et al. efficacy and safety of the cyclooxygenase 2 inhibitors parecoxib and valdecoxib in patients undergoing coronary artery bypass surgery. J Thorac Cardiovasc Surg. 2003;125:1481 92. 28. Lowenstein E, Hallowell P, Levine FH, et al. Cardiovascular response to large doses of intravenous morphine in man. N Engl J Med. 1969; 281:1389 93. 29. Reiz S, Balfors E, Sorensen MB, et al. isoflurane a powerful coronary vasodilator in patients with coronary artery disease. Anesthesiology. 1983;59:91 7. 30. Slogoff S, Keats AS, Ott E. Preoperative propranolol therapy and aortocoronary bypass operation. JAMA. 1978;240:1487 90. 31. London MJ, Shroyer AL, Grover FL. Fast tracking into the new millennium: an evolving paradigm. Anesthesiology. 1999;91:911 5. 32. Frassdorf J, De Hert S, Schlack W. Anaesthesia and myocardial isch- aemia/reperfusion injury. Br J Anaesth. 2009;103:89 98. Hillis et al 2011 ACCF/AHA CABG Guideline e701 33. Tanaka K, Ludwig LM, Kersten JR, et al. Mechanisms of cardio- protection by volatile anesthetics. Anesthesiology. 2004;100:707 21. 34. Butterworth J, James R, Prielipp RC, et al., CABG Clinical Bench- marking Data Base Participants. Do shorter-acting neuromuscular blocking drugs or opioids associate with reduced intensive care unit or hospital lengths of stay after coronary artery bypass grafting? Anes- thesiology. 1998;88:1437 46. 35. Berendes E, Schmidt C, Van Aken H, et al. Reversible cardiac sym- pathectomy by high thoracic epidural anesthesia improves regional left ventricular function in patients undergoing coronary artery bypass grafting: a randomized trial. Arch Surg. 2003;138:1283 90. 36. Bignami E, Landoni G, Biondi-Zoccai GG, et al. Epidural analgesia improves outcome in cardiac surgery: a meta-analysis of randomized controlled trials. J Cardiothorac Vasc Anesth. 2010;24:586 97. 37. Liu SS, Block BM, Wu CL. 